FindTrial
Sign In

Preeclampsia study on first, second and third trimesters of pregnancy

Prospective Validation of Prediction algorithms for Preeclampsia in the first, second and third Trimesters of pregnancy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012508
Enrollment
10000
Registered
2018-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Liona Chiu Yee Poon
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: singleton pregnancy with live fetus those who sign the Informed Consent Form

Exclusion criteria

Exclusion criteria: multiple pregnancy, non viable fetus and not signing the consent form

Design outcomes

Primary

MeasureTime frame
False positive and true positive for screening for all PreEclampsia and preterm-PE using Bayes theorem based in the first and second trimester of pregnancyTimepoint: December 2017 - 25 subjects with data quality validated by the sponsor have been enrolled december 2018 study outcome data after delivery—

Secondary

MeasureTime frame
false positive and true positive frequencies for screening of SGA neonates and preterm and also deliveries before 37 weeksTimepoint: 37 weeks—

Countries

China, Hong Kong, India, Indonesia, Japan, Singapore, Taiwan, Thailand, Viet Nam

Contacts

Public ContactDr Sudarshan Suresh

Mediscan Systems

msinfo@mediscan.org.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026